Catalyst Pharmaceuticals CPRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:07 PM.
Here's what investors need to know about the announcement.
Earnings
Catalyst Pharmaceuticals beat estimated earnings by 28.12%, reporting an EPS of $0.41 versus an estimate of $0.32.
Revenue was up $42.28 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 9.83% increase in the share price the next day.
Here's a look at Catalyst Pharmaceuticals's past performance:
Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
---|---|---|---|---|
EPS Estimate | 0.21 | 0.19 | 0.17 | 0.14 |
EPS Actual | 0.31 | 0.26 | 0.28 | 0.12 |
Revenue Estimate | 58.09M | 53.62M | 49.21M | 42.75M |
Revenue Actual | 60.76M | 57.24M | 53.11M | 43.09M |
To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.